Avanir Pharmaceuticals, Inc.
Records under this name other than the patents Avanir Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to Avanir Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,659,282 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Term ended Term ended Nov 10, 2025 · From the USPTO record | Term ended | Term ended Nov 10, 2025 | From the USPTO record |
| US 8,227,484 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Term ended Ended no later than Jul 17, 2023 · From the USPTO record | Term ended | Ended no later than Jul 17, 2023 | From the USPTO record |
| US 6,207,674 | Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants Term ended Term ended Dec 22, 2019 · From the USPTO record | Term ended | Term ended Dec 22, 2019 | From the USPTO record |
| US 6,440,980 | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs Term ended Ended no later than Aug 22, 2017 · From the USPTO record | Term ended | Ended no later than Aug 22, 2017 | From the USPTO record |
| US 6,829,455 | Driving Force Transmission Mechanism, Image Forming Apparatus Equipped with Such a Mechanism, and Process Unit of Such an Apparatus Formerly held Lapsed on the fee record Ended Dec 7, 2016 · High confidence | Lapsed on the fee record | Ended Dec 7, 2016 | High confidence |
| US 7,442,373 | Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax Formerly held Lapsed on the fee record Ended Oct 28, 2016 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2016 | From the USPTO record |
| US 7,438,909 | Immunization and treatment methods for anthrax Formerly held Lapsed on the fee record Ended Oct 21, 2016 · From the USPTO record | Lapsed on the fee record | Ended Oct 21, 2016 | From the USPTO record |
| US RE38,115 | Dextromethorphan and an oxidase inhibitor for treating intractable conditions Term ended Term ended Sep 19, 2016 · From the USPTO record | Term ended | Term ended Sep 19, 2016 | From the USPTO record |
| US 7,235,565 | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same Lapsed on the fee record Ended Jun 26, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2015 | From the USPTO record |
| US 7,230,106 | Process for the preparation of inhibitors of macrophage migration inhibitory factor Lapsed on the fee record Ended Jun 12, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2015 | From the USPTO record |